Following SpaceX's record-setting initial public offering (IPO), three U.S. House members made significant investments in the company's stock, raising concerns regarding potential conflicts of interest. The IPO took place on June 12, 2026, with shares priced at $135, ultimately garnering around $75 billion in capital.

In the aftermath of the IPO, SpaceX's stock experienced considerable growth, closing at approximately $192.50 on June 15 and reaching peaks of $225 shortly thereafter. On the day of this notable price surge, Rep. Daniel Meuser disclosed a purchase of SpaceX stock between $15,001 and $50,000, attributed to a dependent child, at an average price of $192.50.

Rep. John McGuire also reported buying SpaceX shares on the same day, in the range of $1,001 to $15,000, while Rep. Gilbert Ray Cisneros Jr. followed suit three days later, purchasing shares valued between $1,001 and $15,000 at an average price of $185.

Background on SpaceX's IPO

These transactions occurred shortly after SpaceX's IPO, which has been described as the largest in history. The strong investor demand significantly pushed the stock price beyond the initial offering price, reflecting intense interest from the market. SpaceX’s valuation soared to around $2 trillion post-IPO, solidifying its position among the world’s most valuable public companies.

Potential Conflicts of Interest

The trades raise questions given that all three lawmakers serve on committees pertinent to SpaceX's operations. Rep. Meuser is affiliated with the House Financial Services Committee, while Reps. McGuire and Cisneros are associated with the House Armed Services Committee. SpaceX is a key contractor for the U.S. government, heavily involved in national security projects through its launch services and Starlink satellite network.

Despite the legality of these stock transactions under the STOCK Act, critics argue that such investments by lawmakers in companies impacted by federal policy could lead to conflicts of interest. Following these trades, SpaceX's stock has seen volatility, with current valuations hovering around $145 as the market reassesses growth prospects and other key factors.

This article is for informational purposes only and does not constitute financial advice.